-+ 0.00%
-+ 0.00%
-+ 0.00%
Lizhu Pharmaceutical (01513): Wanbai soup granules obtained the “Drug Registration Certificate”
Share
Listen to the news

Zhitong Finance App News, Livzon Pharmaceutical (01513) issued an announcement. Recently, Sichuan Guangda Pharmaceutical Co., Ltd. (Sichuan Everbright), a subsidiary of Livzon Pharmaceutical Group Co., Ltd. (the Company), received a “Drug Registration Certificate” (certificate number: 2026S03950) issued by the State Drug Administration for the registration application of complete soup granules (this product).

The prescription for this product originates from “Fu Qing's Master's Family” by Fu Shan in the Qing Dynasty, and has been included in the “Catalogue of Ancient Classic Famous Formulas (First Batch)” by the State Administration of Traditional Chinese Medicine. According to the original text of the book, this recipe is a classic prescription for treating sicknesses. Its function is to “nourish the spleen and liver, relieve moisture and stop the cough. It is used for intravenous diseases, liver depression, spleen deficiency, and emptiness. The symptoms are white or light yellow, pale and odorless, pale skin, dry stools, pale moss on the tongue, slow pulse or weak wetness”. The core treatment idea of the formula is to relieve the spleen and liver and relieve constipation.

This prescription has been repeatedly recorded in female doctors' cases. Many clinical and experimental studies have also been carried out in modern times, and has been included in the “Formulation” planning textbook; as a commonly used prescription in gynecology, it is widely used in people with severe spleen deficiency, such as chronic pelvic inflammatory disease, vaginitis, and cervicitis.

As of the disclosure date of this announcement, the total direct investment in R&D expenses of Wantai soup pellets was approximately RMB 4.474,600.

This product is the first to be approved for marketing in China. It is also the second Class 3.1 new drug approved by the company. It further enriches the company's product pipeline and helps enhance the market competitiveness of the company's products. After the launch of this product, it can promote the widespread application of classic famous recipes in clinical practice, help improve the clinical diagnosis and treatment service capabilities of traditional Chinese medicine, and at the same time improve the convenience of patient medication use.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending